Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyaluronidase as an adjuvant to bupivacaine in ultrasound-guided supraclavicular brachial plexus block
PACTR202412466230537Phase 2Completed
- Start
- Mar 2022
- Modality
- Small Molecules, Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of hyaluronidase and bupivacaine in Not applicable (3 arms), sponsored by None. Primary endpoints: Duration of sensory block and Pain relief. Started Mar 2022; status: completed.
02
Drugs
hyaluronidasebupivacaine
03
Conditions
Not applicable
Beyond the preview
Go deeper on PACTR202412466230537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202412466230537.